18 FDG PET/MRI in Histiocytic Sarcoma of the Spinal Canal

Kohei Hirota1, Feibi Zeng1, Junko Inoue Inukai1

  • 1Department of Radiology, Kobe University Graduate School of Medicine, Kobe, Japan.

PubMed

Insights

This study reports a rare case of histiocytic sarcoma involving the central nervous system. Positron emission tomography/magnetic resonance imaging (PET/MRI) effectively evaluated lesion extent and treatment response.

Area of Science:

  • Oncology
  • Neurology
  • Radiology

Background:

  • Histiocytic sarcoma is a rare malignant neoplasm of mature histiocytes.
  • Central nervous system involvement by histiocytic sarcoma is exceptionally uncommon.
  • Accurate staging and treatment monitoring are crucial for managing this rare malignancy.

Purpose of the Study:

  • To report a rare case of histiocytic sarcoma with central nervous system involvement.
  • To illustrate the utility of 18F-FDG PET/MRI in diagnosing and monitoring histiocytic sarcoma.
  • To demonstrate the role of PET/MRI in assessing treatment response during chemotherapy.

Main Methods:

  • A 49-year-old male patient with a lumbar spinal canal mass underwent 18F-FDG PET/MRI.
  • Histopathological examination of the spinal lesion confirmed histiocytic sarcoma.
  • Serial 18F-FDG PET/MRI scans were performed to evaluate changes during chemotherapy.

Main Results:

  • 18F-FDG PET/MRI revealed intense FDG uptake in the primary spinal mass.
  • Metastatic lesions were identified in the cerebellopontine angle and cervical lymph nodes.
  • Changes in FDG uptake on PET/MRI correlated with treatment response during chemotherapy.

Conclusions:

  • 18F-FDG PET/MRI is a valuable tool for evaluating the extent of histiocytic sarcoma.
  • PET/MRI demonstrates efficacy in monitoring treatment response for histiocytic sarcoma.
  • This case underscores the importance of advanced imaging in rare oncological conditions.